elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36066539-90580E70-AE98-4674-A9FB-47A5607595F0
Q36066539-90580E70-AE98-4674-A9FB-47A5607595F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066539-90580E70-AE98-4674-A9FB-47A5607595F0
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.
P2860
Q36066539-90580E70-AE98-4674-A9FB-47A5607595F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066539-90580E70-AE98-4674-A9FB-47A5607595F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b0902215025d68add8586fe90f0c510e7e629c9
P2860
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.